Dr. Arsheed Ahmad Ganaie

Assistant Professor

Curriculum Vitae

Contact Info

  • arsheed.ganaie@gmail.com
  • 8491070304

Research Links

Overview

11

Publications

11

Conferences

0

Books

0

Book Chapters

8

Projects

1

FDP/ Workshops

5

Scholars

1

Patents

Overview

13

Total Publications

AuthorTypeTotal
First Author6
Corresponding Author1
Co-Author4
IndexingTotal
UGC-CARE List Group II (Web of Science Only)1
UGC-CARE List Group II (Both Scopus and Web of Science)8

Publication Details

 
1. The potential modulation of gut microbiota and oxidative stress by dietary carotenoid pigments
Acceptance Date 02-09-2023
Publication Date Online 02-09-2023
Publication Date 10-09-2023
DOI https://doi.org/10.1080/10408398.2023.2254383
Number of Authors 10
ISSN 1040-8398
EISSN 1549-7852
Journal CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
Listed In Thomson True
Impact Factor 14.33
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 64
Issue Number 33
Web Link https://www.tandfonline.com/doi/full/10.1080/10408398.2023.2254383
Web Link Journal https://www.tandfonline.com/journals/bfsn20
Proof
Author Type Co-Author
Author Serial 4
Affiliating Institute Islamic University of Science and Technology, Kashmir
2. Antibacterial potential of Thymus linearis essential oil collected from Wasturwan mountain: A combination of experimental and theoretical studies involving in silico molecular docking simulation of the major compounds against Novobiocin-resistant mutant of DNA Gyrase-B
Acceptance Date 31-07-2023
Publication Date Online 18-08-2023
Publication Date 18-08-2023
DOI https://doi.org/10.1016/j.micpath.2023.106280
Number of Authors 12
ISSN 0882-4010
EISSN 1096-1208
Journal Microbial Pathogenesis
Listed In Thomson True
Impact Factor 3.7
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Web of Science Only)
Volume Number 183
Issue Number 0
Web Link https://www.sciencedirect.com/science/article/abs/pii/S0882401023003133
Web Link Journal https://www.sciencedirect.com/journal/microbial-pathogenesis
Proof
Author Type Corresponding Author
Author Serial 12
Affiliating Institute Islamic University of Science and Technology, Awantipora
3. A novel terpenoid class for prevention and treatment of KRAS-driven cancers: Comprehensive analysis using in situ, in vitro, and in vivo model systems. Ganaie AA, Siddique HR, Sheikh IA, Parray A, Wang L, Panyam J, Villalta PW, Deng Y, Konety BR, Saleem M
Acceptance Date 25-12-2021
Publication Date Online 25-12-2021
Publication Date 25-12-2021
DOI 10.1002/mc.23200. Epub 2020 Apr 15.
Number of Authors 9
ISSN NA
EISSN 1098-2744
Journal Mol Carcinog
Listed In Thomson True
Impact Factor 5.139
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 59
Issue Number 8
Web Link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334075/pdf/nihms-1591431.pdf
Web Link Journal https://onlinelibrary.wiley.com/journal/10982744
Proof
Author Type First Author
Author Serial 1
Affiliating Institute University of Minnesota, USA
4. Ganaie AA, Hussain T, Ferrari M, et al., …M Saleem. (2021) Identifying novel genetic mechanism underlying ADT resistance in African American patients
Acceptance Date 25-12-2021
Publication Date Online 25-12-2021
Publication Date 25-12-2021
DOI
Number of Authors 1
ISSN
EISSN
Journal
Listed In Thomson False
Impact Factor
Source of Impact Factor
UGC Care List
Volume Number
Issue Number
Web Link
Web Link Journal
Proof
Author Type
Author Serial 1
Affiliating Institute
5. Ganaie AA, Maqbool R, Beigh FA, Umbreen S, Dulyaninova N G, Konety B R and Saleem M. Developing novel inhibitors of S100A4 for neuroendocrine (NE) and metastatic prostate cancer: systematic testing using relevant models and drug development techniques (Ac
Acceptance Date 25-12-2021
Publication Date Online 25-12-2021
Publication Date 25-12-2021
DOI
Number of Authors 1
ISSN
EISSN
Journal
Listed In Thomson False
Impact Factor
Source of Impact Factor
UGC Care List
Volume Number
Issue Number
Web Link
Web Link Journal
Proof
Author Type
Author Serial 1
Affiliating Institute
6. Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical Predictor
Acceptance Date 25-09-2020
Publication Date Online 30-09-2020
Publication Date 30-09-2020
DOI 10.1158/1535-7163.MCT-20-0410.
Number of Authors 14
ISSN NA
EISSN 1538-8514
Journal Molecular Cancer Therapeutics
Listed In Thomson True
Impact Factor 5.5
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 19
Issue Number 12
Web Link https://pubmed.ncbi.nlm.nih.gov/32999046/
Web Link Journal https://aacrjournals.org/mct
Proof
Author Type First Author
Author Serial 1
Affiliating Institute University of Minnesota
7. Identifying and treating ROBO1-ve /DOCK1+ve prostate cancer: An aggressive cancer subtype prevalent in African American patients
Acceptance Date 19-07-2020
Publication Date Online 20-07-2020
Publication Date 20-07-2020
DOI doi: 10.1002/pros.24018. Epub 2020 Jul 20.
Number of Authors 13
ISSN 10970045
EISSN 02704137
Journal The Prostate
Listed In Thomson True
Impact Factor 2.7
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 80
Issue Number 13
Web Link https://onlinelibrary.wiley.com/doi/10.1002/pros.24018
Web Link Journal https://onlinelibrary.wiley.com/journal/10970045
Proof
Author Type Co-Author
Author Serial 2
Affiliating Institute University of Minnesota, USA
8. COMMD3:BMI1 Fusion and COMMD3 Protein Regulate C-MYC Transcription: Novel Therapeutic Target for Metastatic Prostate Cancer
Acceptance Date 25-10-2019
Publication Date Online 01-11-2019
Publication Date 01-11-2019
DOI https://doi.org/10.1158/1535-7163.MCT-19-0150
Number of Authors 13
ISSN NA
EISSN 1538-8514
Journal Molecular Cancer Therapeutics
Listed In Thomson True
Impact Factor 5.5
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 18
Issue Number 11
Web Link https://pubmed.ncbi.nlm.nih.gov/31467179/
Web Link Journal https://aacrjournals.org/mct
Proof
Author Type Co-Author
Author Serial 5
Affiliating Institute University of Minnesota
9. Characterization of Novel Murine and Human PDAC Cell Models: Identifying the Role of Intestine Specific Homeobox Gene ISX in Hypoxia and Disease Progression
Acceptance Date 03-05-2019
Publication Date Online 25-08-2019
Publication Date 25-08-2019
DOI 10.1016/j.tranon.2019.05.002
Number of Authors 16
ISSN 19447124
EISSN 1936-5233
Journal Translational Oncology
Listed In Thomson True
Impact Factor 5.01
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 12
Issue Number 8
Web Link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556561/pdf/main.pdf
Web Link Journal https://www.sciencedirect.com/journal/translational-oncology
Proof
Author Type First Author
Author Serial 1
Affiliating Institute University of Minnesota
10. Differential thermal stability, conformational stability and unfolding behavior of Eis proteins from Mycobacterium smegmatis and Mycobacterium tuberculosis
Acceptance Date 04-03-2019
Publication Date Online 25-03-2019
Publication Date 25-03-2019
DOI https://doi.org/10.1371/journal.pone.0213933
Number of Authors 3
ISSN NA
EISSN 932-6203.
Journal PlosOne
Listed In Thomson True
Impact Factor 2.95
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Web of Science Only)
Volume Number 14
Issue Number 4
Web Link https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0213933
Web Link Journal https://journals.plos.org/plosone/
Proof
Author Type Co-Author
Author Serial 2
Affiliating Institute Institute of Microbial Technology, Chandigarh
11. BMI1 Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is A Potential Therapeutic Target: Hypothesis Tested in Race-specific Models
Acceptance Date 07-08-2018
Publication Date Online 07-08-2018
Publication Date 07-08-2018
DOI 10.1158/1078-0432.CCR-18-1394. Epub 2018 Aug 7.
Number of Authors 16
ISSN 15573265
EISSN 1078-0432
Journal Clinical Cancer Research
Listed In Thomson True
Impact Factor 9.26
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 24
Issue Number 24
Web Link https://pubmed.ncbi.nlm.nih.gov/30087142/
Web Link Journal https://aacrjournals.org/clincancerres
Proof
Author Type First Author
Author Serial 1
Affiliating Institute University of Minnesota
12. Interaction of Erp Protein of Mycobacterium tuberculosis with Rv2212 Enhances Intracellular Survival of Mycobacterium smegmatis.
Acceptance Date 22-09-2016
Publication Date Online 15-10-2016
Publication Date 15-10-2016
DOI doi: 10.1128/JB.00120-16. Print 2016 Oct 15.
Number of Authors 9
ISSN NA
EISSN 1098-5530
Journal Journal of bacteriology
Listed In Thomson True
Impact Factor 3.6
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 198
Issue Number 20
Web Link https://pubmed.ncbi.nlm.nih.gov/27481930/
Web Link Journal https://journals.asm.org/journal/jb
Proof
Author Type First Author
Author Serial 1
Affiliating Institute Institute of Microbial Technology, Imtech Chandigarh
13. Thermostable hexameric form of Eis (Rv2416c) protein of M. tuberculosis plays an important role for enhanced intracellular survival within macrophages.
Acceptance Date 25-10-2011
Publication Date Online 16-11-2011
Publication Date 16-11-2011
DOI doi: 10.1371/journal.pone.0027590. Epub 2011 Nov 16.
Number of Authors 4
ISSN NA
EISSN 1932-6203
Journal PlosOne
Listed In Thomson True
Impact Factor 3.95
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 6
Issue Number 11
Web Link https://pubmed.ncbi.nlm.nih.gov/22110681/
Web Link Journal https://journals.plos.org/plosone/
Proof
Author Type First Author
Author Serial 1
Affiliating Institute Institute of Microbial Technology, Chandigarh

Overview

11

Total

LevelTotal
International (Abroad)8
International (Within Country)1
National2

Conference / Seminar Details

ParticipationPaper TitleTitle of Conference/SeminarISBNFromTo
Participiant Regional investigators meet, UOK, Srinagar, Igniting Curiosity and Training Young Minds of J&K For Sustainable Future 19-09-202321-09-2023
Keynote Speaker / Invited TalkThe Role of Molecular Decoys in Anti-Androgen Therapy Resistance in Prostate Cancer"Biotechnological Interventions in Animal Production and Therapeutics (BIAPT-2023)’ at SKUAST-K w.e.f 22-27 May 2023. 22-05-202327-05-2023
Paper Presented / PublishedAbstract 5851: Identifying novel genetic mechanism underlying ADT resistance in African American patientsAACR anual Conference 2018ISSN 0008-547222-05-202327-05-2023
Participiant "Artificial Intelligence in Modern Biology" 23-08-202228-08-2022
Participiant " Emerging Trends Based on Artificial Intelligence & Machine Learning in Food Processing 23-03-202225-03-2022
Paper Presented / PublishedAbstract 5014: Identifying and treating robolv/dock]ive prostate cancer: An aggressive cancer type highly prevalent in African-American patientsAACR anual Conference 2020ISSN 0008-547222-07-202024-07-2020
Paper Presented / PublishedAbstract 343: Identifying a novel and aggressive CD52+ve type of prostate cancer: Phenotype distinguishing biomarker and therapeutic targetAACR anual Conference 2020ISSN 0008-547222-06-202024-06-2020
Paper Presented / PublishedAbstract 1586: Developing novel inhibitors of S100A4 for neuroendocrine (NE) and metastatic prostate cancer: systematic testing using relevant models and drug development techniquesAACR anual Conference 2017ISSN 0008-547201-04-201705-05-2024
Paper Presented / PublishedAbstract 1246: Development of a novel KRAS-targeting agent: systematic validation using in silico, in solution, cell models, PDX and transgenic mouse models EREBAACR anual Conference 2017ISSN 0008-547201-04-201705-04-2017
Paper Presented / PublishedAbstract 1821: Identifying a novel mechanism underlying the enzalutamide and bicalutamide resistance in African- American prostate cancer patientsAACR anual Conference 2016ISSN 0008-547216-04-201620-04-2016
Participiant Basic Flowcytometry Training Course on BD FACSCalibur from 12th 12-12-201114-12-2021

Overview

0

Total Books

0

Book Chapters

Books / Chapters Details

Overview

8

Total

Project StatusTotal ProjectsGrant In Aid
Completed2₹1,64,70,120.00
Ongoing6₹12,72,21,337.00

Projects Details

Genome-Wide Association Study of Diabetes in the Homogenous Kashmiri Population using Genome India Data: Unrevelling Genetic Susceptibility, Clinico-Pathopysiological Correlates, and Cross-Population Replication in Indian, European, American and Asian Cohorts

DBT ( PI ) |
Grant In AidTenure In MonthsYearStatus
₹50,00,000.003609-02-2026Ongoing

Exploring the Role of TGF-β Pseudoreceptor BAMBI-Driven Androgen Deprivation Therapy-Induced Muscle Wasting in Prostate Cancer Cachexia

DBT ( PI ) |
Grant In AidTenure In MonthsYearStatus
₹1,85,22,705.003618-11-2025Ongoing

To investigate the role of Genetic determinants in the low incidence of prostate cancer (PCa) among Kashmiri Population

JKST&IC ( PI ) |
Grant In AidTenure In MonthsYearStatus
₹5,00,000.003029-01-2024Ongoing

Development and Characterization of Novel in vitro models for Gastric Cancers from Kashmiri Patients

JKST&IC ( Co-PI ) |
Grant In AidTenure In MonthsYearStatus
₹5,50,000.003029-01-2024Ongoing

Establishment of an interdisciplinary Science and Technology Research Program for Chronic Diseases,

DST PURSE ( Co-PI ) |
Grant In AidTenure In MonthsYearStatus
₹9,76,13,800.004820-04-2023Ongoing

Systems biology-based identification and validation of potential novel therapeutic agents for Head and Neck Squamous Cell Carcinoma

SERB-DST ( Co-PI ) |
Grant In AidTenure In MonthsYearStatus
₹51,10,120.003603-03-2022Completed

To Study the Novel Role of Cullin- 3 SPOP E3 Ligase mediated immune surveillance in Prostate Cancer by promoting the degradation of Next generation immune checkpoint inhibitor CD73

SERB-DST ( PI ) |
Grant In AidTenure In MonthsYearStatus
₹50,34,832.003612-01-2022Ongoing

To investigate the role of MDM2 as a Master Regulator and Therapeutic Target in Neuroendocrine Prostate Cancer

DBT- Ramalingaswami Fellowship ( PI ) |
Grant In AidTenure In MonthsYearStatus
₹1,13,60,000.006018-08-2020Completed

Overview

1

NameParticipationTotal
WorkshopParticipant1
DurationTotal
One Week1
Year WiseTotal
20231

FDP / Workshop Details

NameTitleAgencyFunding AgencyDurationModeFromTo
WorkshopCapacity Building Workshop for TeachersDELHI UNIVERSITYIslamic University of Science and TechnologyOne WeekOffline11-09-202314-09-2023

Overview

5

Total

SupervisionPrgCodeStatusTotal
SupervisorPH.D. (CAYSC)Under Superviosn1
SupervisorPh.D. (MM)Under Superviosn4

Research Guidance Details

RegistrationNoPrgCodeBatchResearchTopicFellowshipNameProgrammeCompleted
IUST0125019911PH.D. (MM)2025Not Assigned YetIUST-Fellowship
IUST0125021820PH.D. (CAYSC)2025Not Assigned YetIUST-Fellowship
IUST0123016789Ph.D. (MM)2023Implications of Wnt/β– Catenin Signaling in Drug Resistance and Progression of Prostate CancerIUST-Fellowship
IUST0123017742Ph.D. (MM)2023Cullin-3 SPOP E3 Ligase in Prostate Cancer: Molecular Mechanisms and Tumorigenic PotentialNILL
IUST0121015670Ph.D. (MM)2021not assigned yetMANF
Overview

LevelTotal
International3
National6

PatentTypePatentStatusTotal
PatentPublished1

LevelTypeAwardNameAwardingAgencyYear
NationalFellowshipRamalingswami FellowshipDepartment of Biotechnology2020
InternationalAwardYoung investigators AwardSBUR2017
NationalAwardJunior Research FellowhipCSIR-HRD2023
NationalAwardCommon Entrance test of Biotechnology (CEEB), JNUDepartment of Biotechnology2023
NationalAwardNational Eligibility TestCSIR-HRD2023
InternationalFellowshipPostdoctoral FellowshipUMN2016
NationalFellowshipJunior Research FellowshipCSIR-UGC2023
InternationalAwardYoung investigators AwardAACR1997
NationalFellowshipDBT JRFDepartment of Biotechnology2008

ApplicationNoPatentTitleFilingDatePublishingDatePatentTypePatentStatus
0110.000654US60Targeting Neuroendocrine Prostate Cancer with small molecule inhibitors07-08-202107-10-2021PatentPublished